Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain
Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of ox...
Gespeichert in:
Veröffentlicht in: | Brain research 1998-07, Vol.799 (1), p.78-83 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 83 |
---|---|
container_issue | 1 |
container_start_page | 78 |
container_title | Brain research |
container_volume | 799 |
creator | Kokoshka, Jerry M Metzger, Ryan R Wilkins, Diana G Gibb, James W Hanson, Glen R Fleckenstein, Annette E |
description | Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [
3
H
]serotonin ([
3
H
]5HT) and [
3
H
]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [
3
H
]5HT transport; an effect attributable to a decrease in
V
max. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [
3
H
]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment. |
doi_str_mv | 10.1016/S0006-8993(98)00472-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80011552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899398004727</els_id><sourcerecordid>16485342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-b33c57bbb5beb21aea3032ea0f37cdb3e7e593f2377d38f5e504b550e5152c463</originalsourceid><addsrcrecordid>eNqFkU1P3DAQhi3UCrbQn4CUA6qoRNrxVz5OVYVaQKLqofRs2c6ENUqcYDtI--_xsqu9crKteR6P_Q4h5xS-UaDV938AUJVN2_LLtvkKIGpW1kdkRZu8qZiAD2R1QE7Ipxif8pHzFo7JcVtVFTRiRcwfTGs9zmtMenQeixRQpxF9KoKeXTdsCufXzrgUi4hhSpN3_qowSyr8lIrHYcmeTniVRe3jPIWEIWYn66kwQTt_Rj72eoj4eb-ekv-_fz1c35b3f2_urn_el1YwSKXh3MraGCMNGkY1ag6coYae17YzHGuULe8Zr-uON71ECcJICSipZFZU_JR82d07h-l5wZjU6KLFYdAepyWqBoBSKdm7IK1EI7nYgnIH2jDFGLBXc3CjDhtFQW2HoN6GoLYJq7ZRb0NQdfbO9w0WM2J3sPap5_rFvq6j1UOfk7MuHjDGBWVy-6EfOwxzai8Og4rWobfYuYA2qW5y7zzkFSFApN8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16485342</pqid></control><display><type>article</type><title>Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Kokoshka, Jerry M ; Metzger, Ryan R ; Wilkins, Diana G ; Gibb, James W ; Hanson, Glen R ; Fleckenstein, Annette E</creator><creatorcontrib>Kokoshka, Jerry M ; Metzger, Ryan R ; Wilkins, Diana G ; Gibb, James W ; Hanson, Glen R ; Fleckenstein, Annette E</creatorcontrib><description>Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [
3
H
]serotonin ([
3
H
]5HT) and [
3
H
]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [
3
H
]5HT transport; an effect attributable to a decrease in
V
max. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [
3
H
]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(98)00472-7</identifier><identifier>PMID: 9666084</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Amino Acid Transport System X-AG ; Animals ; ATP-Binding Cassette Transporters - metabolism ; Biological and medical sciences ; Carrier Proteins - antagonists & inhibitors ; Corpus Striatum - drug effects ; Corpus Striatum - metabolism ; Glutamate ; Glutamic Acid - pharmacokinetics ; Male ; Medical sciences ; Membrane Glycoproteins - antagonists & inhibitors ; Membrane Transport Proteins ; Methamphetamine ; Methamphetamine - pharmacology ; Nerve Tissue Proteins ; Neuropharmacology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Sprague-Dawley ; Serotonin ; Serotonin - pharmacokinetics ; Serotonin Plasma Membrane Transport Proteins ; Striatum ; Synaptosomes - drug effects ; Synaptosomes - metabolism ; Time Factors ; Transporter ; Xanthine Oxidase - pharmacology</subject><ispartof>Brain research, 1998-07, Vol.799 (1), p.78-83</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1998 INIST-CNRS</rights><rights>Copyright 1998 Elsevier Science B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-b33c57bbb5beb21aea3032ea0f37cdb3e7e593f2377d38f5e504b550e5152c463</citedby><cites>FETCH-LOGICAL-c420t-b33c57bbb5beb21aea3032ea0f37cdb3e7e593f2377d38f5e504b550e5152c463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006899398004727$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2341256$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9666084$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kokoshka, Jerry M</creatorcontrib><creatorcontrib>Metzger, Ryan R</creatorcontrib><creatorcontrib>Wilkins, Diana G</creatorcontrib><creatorcontrib>Gibb, James W</creatorcontrib><creatorcontrib>Hanson, Glen R</creatorcontrib><creatorcontrib>Fleckenstein, Annette E</creatorcontrib><title>Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [
3
H
]serotonin ([
3
H
]5HT) and [
3
H
]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [
3
H
]5HT transport; an effect attributable to a decrease in
V
max. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [
3
H
]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment.</description><subject>Amino Acid Transport System X-AG</subject><subject>Animals</subject><subject>ATP-Binding Cassette Transporters - metabolism</subject><subject>Biological and medical sciences</subject><subject>Carrier Proteins - antagonists & inhibitors</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - metabolism</subject><subject>Glutamate</subject><subject>Glutamic Acid - pharmacokinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - antagonists & inhibitors</subject><subject>Membrane Transport Proteins</subject><subject>Methamphetamine</subject><subject>Methamphetamine - pharmacology</subject><subject>Nerve Tissue Proteins</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin</subject><subject>Serotonin - pharmacokinetics</subject><subject>Serotonin Plasma Membrane Transport Proteins</subject><subject>Striatum</subject><subject>Synaptosomes - drug effects</subject><subject>Synaptosomes - metabolism</subject><subject>Time Factors</subject><subject>Transporter</subject><subject>Xanthine Oxidase - pharmacology</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1P3DAQhi3UCrbQn4CUA6qoRNrxVz5OVYVaQKLqofRs2c6ENUqcYDtI--_xsqu9crKteR6P_Q4h5xS-UaDV938AUJVN2_LLtvkKIGpW1kdkRZu8qZiAD2R1QE7Ipxif8pHzFo7JcVtVFTRiRcwfTGs9zmtMenQeixRQpxF9KoKeXTdsCufXzrgUi4hhSpN3_qowSyr8lIrHYcmeTniVRe3jPIWEIWYn66kwQTt_Rj72eoj4eb-ekv-_fz1c35b3f2_urn_el1YwSKXh3MraGCMNGkY1ag6coYae17YzHGuULe8Zr-uON71ECcJICSipZFZU_JR82d07h-l5wZjU6KLFYdAepyWqBoBSKdm7IK1EI7nYgnIH2jDFGLBXc3CjDhtFQW2HoN6GoLYJq7ZRb0NQdfbO9w0WM2J3sPap5_rFvq6j1UOfk7MuHjDGBWVy-6EfOwxzai8Og4rWobfYuYA2qW5y7zzkFSFApN8</recordid><startdate>19980713</startdate><enddate>19980713</enddate><creator>Kokoshka, Jerry M</creator><creator>Metzger, Ryan R</creator><creator>Wilkins, Diana G</creator><creator>Gibb, James W</creator><creator>Hanson, Glen R</creator><creator>Fleckenstein, Annette E</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19980713</creationdate><title>Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain</title><author>Kokoshka, Jerry M ; Metzger, Ryan R ; Wilkins, Diana G ; Gibb, James W ; Hanson, Glen R ; Fleckenstein, Annette E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-b33c57bbb5beb21aea3032ea0f37cdb3e7e593f2377d38f5e504b550e5152c463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Amino Acid Transport System X-AG</topic><topic>Animals</topic><topic>ATP-Binding Cassette Transporters - metabolism</topic><topic>Biological and medical sciences</topic><topic>Carrier Proteins - antagonists & inhibitors</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - metabolism</topic><topic>Glutamate</topic><topic>Glutamic Acid - pharmacokinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - antagonists & inhibitors</topic><topic>Membrane Transport Proteins</topic><topic>Methamphetamine</topic><topic>Methamphetamine - pharmacology</topic><topic>Nerve Tissue Proteins</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin</topic><topic>Serotonin - pharmacokinetics</topic><topic>Serotonin Plasma Membrane Transport Proteins</topic><topic>Striatum</topic><topic>Synaptosomes - drug effects</topic><topic>Synaptosomes - metabolism</topic><topic>Time Factors</topic><topic>Transporter</topic><topic>Xanthine Oxidase - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kokoshka, Jerry M</creatorcontrib><creatorcontrib>Metzger, Ryan R</creatorcontrib><creatorcontrib>Wilkins, Diana G</creatorcontrib><creatorcontrib>Gibb, James W</creatorcontrib><creatorcontrib>Hanson, Glen R</creatorcontrib><creatorcontrib>Fleckenstein, Annette E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kokoshka, Jerry M</au><au>Metzger, Ryan R</au><au>Wilkins, Diana G</au><au>Gibb, James W</au><au>Hanson, Glen R</au><au>Fleckenstein, Annette E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1998-07-13</date><risdate>1998</risdate><volume>799</volume><issue>1</issue><spage>78</spage><epage>83</epage><pages>78-83</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [
3
H
]serotonin ([
3
H
]5HT) and [
3
H
]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [
3
H
]5HT transport; an effect attributable to a decrease in
V
max. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [
3
H
]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>9666084</pmid><doi>10.1016/S0006-8993(98)00472-7</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-8993 |
ispartof | Brain research, 1998-07, Vol.799 (1), p.78-83 |
issn | 0006-8993 1872-6240 |
language | eng |
recordid | cdi_proquest_miscellaneous_80011552 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Amino Acid Transport System X-AG Animals ATP-Binding Cassette Transporters - metabolism Biological and medical sciences Carrier Proteins - antagonists & inhibitors Corpus Striatum - drug effects Corpus Striatum - metabolism Glutamate Glutamic Acid - pharmacokinetics Male Medical sciences Membrane Glycoproteins - antagonists & inhibitors Membrane Transport Proteins Methamphetamine Methamphetamine - pharmacology Nerve Tissue Proteins Neuropharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Rats, Sprague-Dawley Serotonin Serotonin - pharmacokinetics Serotonin Plasma Membrane Transport Proteins Striatum Synaptosomes - drug effects Synaptosomes - metabolism Time Factors Transporter Xanthine Oxidase - pharmacology |
title | Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A41%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methamphetamine%20treatment%20rapidly%20inhibits%20serotonin,%20but%20not%20glutamate,%20transporters%20in%20rat%20brain&rft.jtitle=Brain%20research&rft.au=Kokoshka,%20Jerry%20M&rft.date=1998-07-13&rft.volume=799&rft.issue=1&rft.spage=78&rft.epage=83&rft.pages=78-83&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(98)00472-7&rft_dat=%3Cproquest_cross%3E16485342%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16485342&rft_id=info:pmid/9666084&rft_els_id=S0006899398004727&rfr_iscdi=true |